CLINICAL_TRIALS
trial_result
· 2022-01-21
Clinical Trial Update: The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial [Phase 2, Phase 3]
Summary
A randomized, double-blind, placebo-controlled trial evaluated intravenous mannitol plus saline for preventing cisplatin-induced nephrotoxicity across Phase 2 a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Cis-Platinum Nephropathy, Mannitol Adverse Reaction | Phase 2, Phase 3 | Status: COMPLETED